Crossmark

Low levels of CD3 + and CD8 + T cells in peripheral blood can predict poor efficacy of first-line chemotherapy in patients with angioimmunoblastic T cell lymphoma

Crossref DOI link: https://doi.org/10.1007/s00277-025-06314-0

Published Online: 2025-03-26

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Yanfei

Song, Weiwei

Song, Yuqin

Zhu, Jun

Xie, Yan
Funding

Funding for this research was provided by:

The Capital's Funds for Health Improvement and Research (2022-1-2152, 2022-4-2156 and 2024-1-2151)

National Key Research and Development Program of Chin (2023YFF0613403)

National Natural Science Foundation of China (82070205, 81972807, 81670187, 32300655 and 82300214)

Beijing Natural Science Foundation (L244063 and L244025, L244063)

Cultivation plan in Haidian District (HP2022-19-503004)

Beijing Hospital Authority Cultivation plan (PX2022046)

Beijing Research Ward Excellence Program (BRWEP2024W032150205)
License Information

Text and Data Mining valid from 2025-03-01

Version of Record valid from 2025-03-26
More Information

Article History

Received: 12 July 2024

Accepted: 10 March 2025

First Online: 26 March 2025

Declarations

:

: The study protocol received approval from the Ethics Committee of Peking University Cancer Hospital & Institute, with written informed consent obtained from all participants. All procedures adhered to the Declaration of Helsinki.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below